It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Eating behavior varies greatly between individuals, but the neurobiological basis of these trait-like differences in feeding remains poorly understood. Central μ-opioid receptors (MOR) and cannabinoid CB1 receptors (CB1R) regulate energy balance via multiple neural pathways, promoting food intake and reward. Because obesity and eating disorders have been associated with alterations in the brain’s opioid and endocannabinoid signaling, the variation in MOR and CB1R system function could potentially underlie distinct eating behavior phenotypes. In this retrospective positron emission tomography (PET) study, we analyzed [11C]carfentanil PET scans of MORs from 92 healthy subjects (70 males and 22 females), and [18F]FMPEP-d2 scans of CB1Rs from 35 subjects (all males, all also included in the [11C]carfentanil sample). Eating styles were measured with the Dutch Eating Behavior Questionnaire (DEBQ). We found that lower cerebral MOR availability was associated with increased external eating—individuals with low MORs reported being more likely to eat in response to environment’s palatable food cues. CB1R availability was associated with multiple eating behavior traits. We conclude that although MORs and CB1Rs overlap anatomically in brain regions regulating food reward, they have distinct roles in mediating individual feeding patterns. Central MOR system might provide a pharmacological target for reducing individual’s excessive cue-reactive eating behavior.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Turku PET Centre, University of Turku, Turku, Finland (GRID:grid.470895.7) (ISNI:0000 0004 0391 4481); University of Turku, Clinical Neurosciences, Turku, Finland (GRID:grid.1374.1) (ISNI:0000 0001 2097 1371)
2 Turku PET Centre, University of Turku, Turku, Finland (GRID:grid.470895.7) (ISNI:0000 0004 0391 4481)
3 Turku PET Centre, University of Turku, Turku, Finland (GRID:grid.470895.7) (ISNI:0000 0004 0391 4481); Turku University Hospital, Department of Endocrinology, Turku, Finland (GRID:grid.410552.7) (ISNI:0000 0004 0628 215X)
4 University of Turku, Clinical Neurosciences, Turku, Finland (GRID:grid.1374.1) (ISNI:0000 0001 2097 1371); Turku University Hospital, Neurocenter, Turku, Finland (GRID:grid.410552.7) (ISNI:0000 0004 0628 215X)
5 Turku PET Centre, University of Turku, Turku, Finland (GRID:grid.470895.7) (ISNI:0000 0004 0391 4481); University of Turku and Turku University Hospital, Department of Radiology, Turku, Finland (GRID:grid.1374.1) (ISNI:0000 0001 2097 1371)
6 Turku PET Centre, University of Turku, Turku, Finland (GRID:grid.470895.7) (ISNI:0000 0004 0391 4481); University of Turku, Department of Psychology, Turku, Finland (GRID:grid.1374.1) (ISNI:0000 0001 2097 1371)